AGA Luminal and Fistulizing Crohn’s Disease Pocket Guide (Janssen)

Luminal and Fistulizing Crohn’s Disease Pocket Guide

AGA Luminal and Fistulizing Crohn’s Disease GUIDELINES brought to you courtesy of Guideline Central.

Issue link: https://eguideline.guidelinecentral.com/i/1399717

Contents of this Issue

Navigation

Page 11 of 13

Treatment 12 Table 1. Drug Therapy for the Management of Moderate to Severe CD Drug Induction Maintenance Biologic- naïve induction Infliximab ✔ ✔ ✔* Adalimumab ✔ ✔ ✔* Certolizumab pegol ✔ ✔ Adalimumab + thiopurine vs adalimumab monotherapy ✔ Infliximab + thiopurine vs infliximab monotherapy ✔ Natalizumab × × Ustekinumab ✔ ✔ ✔* Vedolizumab ✔ ✔ ✔* Oral methotrexate monotherapy × × Subcutaneous or intramuscular methotrexate monotherapy ✔ ✔ iopurine monotherapy × ✔ Corticosteroids ✔ × 5-aminosalicylate/sulfasalazine × × Antiobiotic monotherapy Biologic monotherapy vs thiopurine monotherapy ✔ Biologic agents in combination with antibiotics vs biologic monotherapy * Over certolizumab pegol. ✔ = strong recommendation for; ✔ = conditional recommendation for; × = conditional recommendation against; × = strong recommendation against

Articles in this issue

view archives of AGA Luminal and Fistulizing Crohn’s Disease Pocket Guide (Janssen) - Luminal and Fistulizing Crohn’s Disease Pocket Guide